Anthony @ Equity Investigations, Dear Anthony, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ritz who wrote (10655)	2/11/1999 2:04:00 PM
From: Doorman	Read Replies (1) of 122087

Bristol-Myers knows more than you or I -- the fact is that they couldn't reproduce ENMD's results and pulled out of the deal. ENMD isn't even in Ph 1 with this drug yet! This stock is way overvalued...We're talking questionable science and years away from commercialization even in a best case scenario. IMGN has better pre-clinical data as validated by the recent SK deal, and that stock's only at 2 1/2. LOL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next